Clinical trial
Glucose-dependent Insulinotropic Polypeptide - New Role as Blood Glucose Stabilizer?
NCT01048268 is registered in ClinicalTrials.gov with University Hospital, Gentofte, Copenhagen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Glucose-dependent Insulinotropic Polypeptide - New Role as Blood Glucose Stabilizer?
- Lead sponsor
- University Hospital, Gentofte, Copenhagen
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- December 31, 2009
- Completion date
- April 30, 2014
- Enrollment
- 30 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.